José Antonio Castillo Sánchez-rekin lankidetzan egindako argitalpenak (12)

2008

  1. Delayed post-ischemic administration of CDP-choline increases EAAT2 association to lipid rafts and affords neuroprotection in experimental stroke

    Neurobiology of Disease, Vol. 29, Núm. 1, pp. 123-131

2007

  1. A chronic treatment with CDP-choline improves functional recovery and increases neuronal plasticity after experimental stroke

    Neurobiology of Disease, Vol. 26, Núm. 1, pp. 105-111

  2. Neuroplasticity and cellular therapy in cerebral infarction

    Cerebrovascular Diseases

  3. The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome

    Stroke, Vol. 38, Núm. 10, pp. 2759-2764

2006

  1. A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke

    Journal of Experimental Medicine, Vol. 203, Núm. 3, pp. 711-717

  2. Neurorepair versus neuroprotection in stroke

    Cerebrovascular Diseases, Vol. 21, Núm. SUPPL. 2, pp. 54-63

  3. Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J 2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms

    Journal of Cerebral Blood Flow and Metabolism, Vol. 26, Núm. 2, pp. 218-229

  4. Targets of cytoprotection in acute ischemic stroke: Present and future

    Cerebrovascular Diseases, Vol. 21, Núm. SUPPL. 2, pp. 1-8

2005

  1. Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia

    Neurobiology of Disease, Vol. 18, Núm. 2, pp. 375-384

  2. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: Effects on glutamate transport

    Neurobiology of Disease, Vol. 18, Núm. 2, pp. 336-345

  3. TNFR1 upregulation mediates tolerance after brain ischemic preconditioning

    Journal of Cerebral Blood Flow and Metabolism, Vol. 25, Núm. 2, pp. 193-203

2003

  1. L-arginine levels in blood as a marker of nitric oxide-mediated brain damage in acute stroke: A clinical and experimental study

    Journal of Cerebral Blood Flow and Metabolism, Vol. 23, Núm. 8, pp. 978-984